Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells

por Sanlioglu, Ahter D, Dirice, Ercument, Aydin, Cigdem, Erin, Nuray, Koksoy, Sadi, Sanlioglu, Salih
Publicado 2005

Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology

por Eksi, Yunus E, Sanlioglu, Ahter D, Akkaya, Bahar, Ozturk, Bilge Esin, Sanlioglu, Salih
Publicado 2021

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer

por Bisgin, Atil, Kargi, Aysegul, Yalcin, Arzu D, Aydin, Cigdem, Ekinci, Deniz, Savas, Burhan, Sanlioglu, Salih
Publicado 2012

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL

por Aydin, Cigdem, Sanlioglu, Ahter D, Bisgin, Atil, Yoldas, Burcak, Dertsiz, Levent, Karacay, Bahri, Griffith, Thomas S, Sanlioglu, Salih
Publicado 2010

TRAIL and DcR1 Expressions Are Differentially Regulated in the Pancreatic Islets of STZ- versus CY-Applied NOD Mice

por Dirice, Ercument, Kahraman, Sevim, Elpek, Gulsum Ozlem, Aydin, Cigdem, Balci, Mustafa Kemal, Omer, Abdulkadir, Sanlioglu, Salih, Sanlioglu, Ahter Dilsad
Publicado 2011

TRAIL Death Receptor-4, Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8(+ )T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis

por Bisgin, Atil, Terzioglu, Ender, Aydin, Cigdem, Yoldas, Burcak, Yazisiz, Veli, Balci, Nilufer, Bagci, Huseyin, Gorczynski, Reginald M, Akdis, Cezmi A, Sanlioglu, Salih
Publicado 2010